Project Grant R21TR005645
Award Date
6/16/25
Completion Date
6/15/27
Dollars Obligated
$419K
Federal Agency
National Center for Advancing Translational Sciences
Federal Grant Program
93.350
Assistance Type
Project Grant
Place of Performance
California, USA
Similar Awards
The University of California, Irvine has been awarded a $4,099,887 Cooperative Agreement by the National Center for Advancing Translational Sciences (NCATS), a program under the National Institutes of Health (CFDA 93.350). This funding will support the "Institute for Clinical and Translational Science" project, which aims to build the UCI CTSA Hub as an innovative platform for accelerating the translation of scientific discoveries into medical treatments and interventions. The key...
This Project Grant award of $667,379 from the National Cancer Institute (NCI) under the Cancer Treatment Research program (CFDA 93.395) aims to expand the understanding of polyadenylation, a critical process in gene expression, and its implications for human health and disease. The award supports research at the University of California, Irvine to develop computational models that can predict mRNA stability and identify genetic variants that impact polyadenylation efficiency. The work involves a...
The University of California Irvine will use a $2.83 million project grant from the Department of Health and Human Services' National Institute of General Medical Sciences to decipher the mechanism of long-range gene regulation in vivo. Over a three-year period ending August 2025, UC Irvine researchers will utilize efficient enhancer replacement technology in mice to systematically characterize long-range enhancer activity and identify cis-regulatory sequences critical to this function. A...
The University of California Irvine received a $2,709,000 Project Grant from the Department of Health and Human Services Assistant Secretary for Financial Resources under the Biomedical Research and Research Training program (CFDA 93.859) for the period of September 1, 2022 through August 31, 2025. The grant will support the development of a new RNA mapping tool called SMOOTHY-FISH that enables spatially mapping RNA molecules in individual cells with single nucleotide specificity and minimum...
The University of California Irvine received a $500,000 project grant award from the National Science Foundation to support strategy-guided syntheses of complex natural products from July 1, 2021 to June 30, 2024. The award is funded through the NSF's Mathematical and Physical Sciences program (CFDA 47.049), which aims to strengthen the nation's scientific enterprise through increased understanding of major problems. Under the award, UC Irvine will apply strategic methods to synthesize complex...
This $372,210 Project Grant awarded by the National Institute of General Medical Sciences (NIGMS) under CFDA 93.859 Biomedical Research and Research Training program aims to develop synthetic, fluorescent nucleoside analogues and apply them to advance RNA-centered therapeutics. The key products and services to be delivered include: Creating modified antisense oligonucleotides (ASOs) and small interfering RNAs (siRNAs) incorporating fluorescent ribonucleosides to enable live-cell imaging of RNA...
This Project Grant award of $356,462.00 was made by the National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training Program (CFDA 93.859) to the University of California, Irvine. The project aims to develop innovative computational tools for analyzing cell-cell communication using spatial transcriptomic data. The key focus areas include: Improving coverage of ligand/receptor genes in spatial transcriptomic data by using single-cell RNA-seq data...
This Project Grant award of $388,621 from the National Institute of General Medical Sciences (NIGMS) Biomedical Research and Research Training Program (CFDA 93.859) will support the development of novel molecular designs with therapeutic potential. The key objectives are: Developing ligand-heterocycle conjugates as targeted RNA degraders with rapid kinetics and selectivity for cancer-associated G-quadruplexes. Engineering nucleic acid polymers with (thio)phosphoramidate backbones as biostable...
The University of California, Davis received a $201,250 Project Grant award from the National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training program (CFDA 93.859). The award, with a project period from September 1, 2024 to August 31, 2026, will support the development of a nanobody toolkit to study connexin channels, which are crucial for intercellular communication during development and physiology. The research aims to increase understanding...
This Project Grant award of $1,249,099 from the National Institutes of Health (NIH) Trans-NIH Research Support program (CFDA 93.310) supports the development of a new class of small, bright, tunable, and biocompatible near-infrared (NIR-II) fluorescent probes for deep tissue molecular imaging. The University of California, Irvine (UC Irvine) will create a palette of DNA-stabilized silver nanoclusters (AgN-DNA) that emit in the NIR-II tissue transparency window (1,000-1,700 nm). These new...